{"id":"W4405696229","doi":"10.1080/14796694.2024.2442900","title":"Combination niraparib and abiraterone for HRR-altered metastatic castration-resistant prostate cancer","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone acetate; PARP inhibitor; Androgen receptor; Enzalutamide; Oncology; Internal medicine; PARP1; Cancer research; Androgen deprivation therapy; Abiraterone; Cancer; Poly ADP ribose polymerase; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003514772,0.000542506,0.001196442,0.001572071,0.0001605498,0.0005536774,0.0006834145,0.0004722866,0.003464214],"category_scores_gemma":[0.000349641,0.0001960219,0.0006255655,0.001345675,0.0001911561,0.0004997827,0.0003626701,0.001050175,0.001213254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004205784,"about_ca_system_score_gemma":0.0007363516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009575548,"about_ca_topic_score_gemma":0.002846125,"domain_scores_codex":[0.9998498,0.0000285731,0.0000257595,0.00002184509,0.00006143761,0.00001268116],"domain_scores_gemma":[0.999898,0.0000429603,0.00002620052,0.00000275257,0.00002197934,0.000008173386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002133164,0.00007638376,0.0001212016,0.03110701,0.0002471748,0.0001721515,0.00004233287,0.0003584076,0.00194071,0.00098399,0.01475127,0.9499861],"study_design_scores_gemma":[0.0001887545,0.0004888427,0.002046689,0.01080606,0.0007224065,0.002792348,0.00006245733,0.0002497626,0.001363382,0.001070775,0.980181,0.00002747584],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002657888,0.9985523,0.00005413198,0.00007105187,0.00007385147,0.000007794212,0.0000201611,0.000005686185,0.0009492796],"genre_scores_gemma":[0.001429687,0.9976731,0.0001071632,0.0001240821,0.00005831775,0.000008575379,0.00004657191,0.000001262467,0.0005512637],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003464214,"threshold_uncertainty_score":0.01158899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1000884796542603,"score_gpt":0.4641938152395031,"score_spread":0.3641053355852429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}